跳至主要内容
临床试验/NCT07717918
NCT07717918已完成1 期

A Phase 1B Study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Subjects

Bausch & Lomb Incorporated2 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2026年7月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
28
试验地点
2
主要终点
Ocular pain severity assessed by numeric pain rating scale (NPRS)

研究概览

简要总结

Single center, double-masked study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Subjects

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female ≥ 18 to ≤ 65 years of age.
  • In good health, as assessed at Screening by the Investigator from past medical history, physical examination (abbreviated), and laboratory tests.
  • Does not wear contact lenses, or is willing to refrain from wearing contact lenses for the duration of the study.

排除标准

  • Women of childbearing potential or non-vasectomized males with partners of childbearing potential are not eligible unless they are using an effective method of contraception and agree to use an effective method of contraception until at least 30 days after study treatment.
  • Any medical condition (systemic or ophthalmic) that may, in the opinion of the Investigator, preclude the safe administration of IP, safe participation in this study, or confound the assessment of safety or efficacy.
  • Unwilling or unable to comply with the study protocol.

研究组 & 干预措施

BL1332 eye drops

Active Comparator

干预措施: BL1332 eye drops (Drug)

BL1332 Placebo eye drops

Placebo Comparator

干预措施: BL1332 Placebo eye drops (Drug)

结局指标

主要结局

Ocular pain severity assessed by numeric pain rating scale (NPRS)

时间窗: Assessed 5 seconds post-capsaicin dose

NPRS scale 0 to 10, with higher score reflecting worse pain

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验